期刊文献+
共找到8篇文章
< 1 >
每页显示 20 50 100
Pure laparoscopic hepatectomy for hepatocellular carcinoma with chronic liver disease 被引量:21
1
作者 Zenichi Morise Norihiko Kawabe +6 位作者 Jin Kawase Hirokazu Tomishige Hidetoshi Nagata Hisanori Ohshima Satoshi Arakawa Rie Yoshida Masashi Isetani 《World Journal of Hepatology》 CAS 2013年第9期487-495,共9页
Pure laparoscopic hepatectomy is a less invasive procedure than conventional open hepatectomy for the resection of hepatic lesions. Increases in experiences with the technique, in combination with advances in technolo... Pure laparoscopic hepatectomy is a less invasive procedure than conventional open hepatectomy for the resection of hepatic lesions. Increases in experiences with the technique, in combination with advances in technology, have promoted the popularity of pure laparoscopic hepatectomy. However, indications for usage and potential contraindications of the procedure remain unresolved. The characteristics and specific advantages of the procedure, especially for hepatocellular carcinoma(HCC) patients with chronic liver diseases,are reviewed and discussed in this paper. For cirrhotic patients with liver tumors, pure laparoscopic hepatectomy minimizes destruction of the collateral blood and lymphatic flow from laparotomy and mobilization, and mesenchymal injury from compression. Therefore, pure laparoscopic hepatectomy has the specific advantage of minimal postoperative ascites production that leads to lowering the risk of disturbance in water or electrolyte balance and hypoproteinemia. It minimizes complications that routinely trigger postoperative serious liver failure. Under adequate patient positioning and port arrangement, the partial resection of the liver in the area of subphrenic space, peri-inferior vena cava area or next to the attachment of retro-peritoneum is facilitated in pure laparoscopic surgery by providing good vision and manipulation in the small operative field.Furthermore, the features of reduced post-operative adhesion, good vision, and manipulation within the small area between the adhesions make this procedure safer in the context of repeat hepatectomy procedures.These improved features are especially advantageous for patients with liver cirrhosis and multicentric and/or metachronous HCCs. 展开更多
关键词 Laparoscopic HEPATECTOMY Hepatocellular carcinoma liver cirrhosis Chronic liver disease liver Tumor liver RESECTION REPEAT HEPATECTOMY Bridging therapy to transplantation ASCITES postoperative liver failure
下载PDF
影响肝癌肝切除术患者术后肝衰竭的多因素分析 被引量:9
2
作者 唐丽 肖昌倩 《肝胆外科杂志》 2019年第6期462-465,共4页
目的研究肝癌肝切除术患者术后肝衰竭的影响因素。方法回顾我院2016年1月~2019年1月收治的120例原发性肝癌肝切除术患者资料,根据有无术后肝衰竭并发症分为观察组(n=55例)和对照组(n=65),比较两组的患者一般资料、术前一般指标,术中相... 目的研究肝癌肝切除术患者术后肝衰竭的影响因素。方法回顾我院2016年1月~2019年1月收治的120例原发性肝癌肝切除术患者资料,根据有无术后肝衰竭并发症分为观察组(n=55例)和对照组(n=65),比较两组的患者一般资料、术前一般指标,术中相关指标,分析各变量与肝衰竭的关系。结果两组患者的年龄、术前白蛋白含量、凝血酶原时间(PT)、手术时间和肿瘤直径≥10cm、Child-pugh分级C级、术中失血量>1000ml、肝切除术范围M半肝的患者比例均有明显差异,它们均是术后肝衰竭的独立危险因素(P均<0.05)。结论原发性肝癌肝切除术患者术后有肝衰竭的风险,应全面评估相关危险因素,最大化降低肝衰竭风险。 展开更多
关键词 肝癌 肝切除术 术后肝衰竭 影响因素
下载PDF
肝内胆管癌患者根治性手术后肝衰竭和复发的术前危险因素分析
3
作者 陈磊 何超 +4 位作者 刘攀 付强 罗乾坤 张宏伟 秦涛 《肝胆胰外科杂志》 CAS 2024年第3期150-154,共5页
目的通过术前临床因素预测肝内胆管癌(ICC)患者术后发生肝衰竭和1年内复发的危险因素。方法回顾性分析2017年6月至2022年6月于郑州大学人民医院肝胆胰腺外科行根治术的ICC患者的临床资料。根据患者术后肝功能指标将患者分为术后肝衰竭组... 目的通过术前临床因素预测肝内胆管癌(ICC)患者术后发生肝衰竭和1年内复发的危险因素。方法回顾性分析2017年6月至2022年6月于郑州大学人民医院肝胆胰腺外科行根治术的ICC患者的临床资料。根据患者术后肝功能指标将患者分为术后肝衰竭组(n=16)和非肝衰竭组(n=40);按术后1年内是否复发将其分为复发组(n=22)和未复发组(n=34)。采用单因素检验(t检验和χ2检验)分析ICC术后复发和肝衰竭的危险因素。计算血肌酐与胱抑素比值(CCR)预测ICC术后1年内复发和肝衰竭的受试者工作特征(ROC)曲线下面积(AUC),将约登指数最大时的CCR值作为最佳临界值。采用多因素Logistic回归分析患者ICC术后发生肝衰竭和1年内复发的独立危险因素。结果CCR在复发组和非复发组[(53.49±3.90)vs(72.46±2.10)]、肝衰竭组和非肝衰竭组[(54.67±4.49)vs(69.14±2.48)]中差异均有统计学意义(均P<0.05),此外体质量减轻≥5 kg、肝炎病毒定量≥104 IU/ML、肿瘤低分化、肿瘤最大径≥5 cm、肿瘤数目多发、有淋巴结转移是ICC患者术后1年内复发的相关因素;体质量减轻≥5 kg、肝炎病毒定量≥104 IU/mL、肿瘤最大径≥5 cm、肿瘤数目多发、既往胆管疾病史是其术后肝衰竭的相关因素(均P<0.05)。ROC曲线分析显示CCR预测ICC术后1年内复发和肝衰竭的AUC分别为0.814和0.720(均P<0.05),CCR的最佳临界值分别为62.34和64.82。多因素Logistic回归分析结果表明CCR低(OR=22.357,95%CI 1.140-438.308)、肿瘤数目多发(OR=27.050,95%CI 1.029-711.165)、有淋巴结转移(OR=18.046,95%CI 1.333-244.389)、肿瘤分化程度低(OR=18.134,95%CI 1.357-242.359)是ICC术后1年内复发的独立危险因素;肿瘤最大径≥5 cm(OR=8.800,95%CI 2.373-32.635)是ICC术后发生肝衰竭的独立危险因素。结论CCR可作为一种术前预测ICC患者术后肝衰竭和术后1年内复发的临床指标。 展开更多
关键词 肝内胆管癌 术后肝衰竭 复发 血肌酐与胱抑素C比值 术前预测
下载PDF
Laparoscopic liver resection for the treatment of hepatocellular carcinoma 被引量:1
4
作者 Norihiko Kawabe Zenichi Morise +4 位作者 Hirokazu Tomishige Hidetoshi Nagata Jin Kawase Satoshi Arakawa Masashi Isetani 《World Journal of Surgical Procedures》 2015年第1期137-141,共5页
Accumulation of experiences and technological advances after the first report of laparoscopic liver resection(LLR) are now revealing the characteristics and specific advantages of this approach, especially for hepatoc... Accumulation of experiences and technological advances after the first report of laparoscopic liver resection(LLR) are now revealing the characteristics and specific advantages of this approach, especially for hepatocellular carcinoma(HCC) patients with chronic liver diseases(CLD). Inlaparoscopic approach, there are minimum needs for:(1) laparotomy and dissection of the attachments and adhesion which may cause destructions in the collateral blood and lymphatic flows; and(2) compression of the liver which may cause parenchymal damage for the liver resection(LR). These are especially beneficial for the patients with CLD. LLR results in minimal postoperative ascites and the other complications, which could potentially lead to lowering the risk of fatal liver failure. These characteristics of LLR facilitate surgical treatment application to the patients of HCC with background CLD. Laparoscopic approach also results in improved vision and manipulation in a small operative field under several conditions, including the cases where it is necessary to perform repeat LR between adhesions. These characteristics make LLR safer and more accessible to the repeat treatment, such as multicentric and metachronous lesions in the cirrhotic liver. These advantages of LLR indicate it is a superior method than open LR under certain conditions in patients of HCC with background CLD. 展开更多
关键词 Laparoscopic HEPATECTOMY Hepatocellular carcinoma liver cirrhosis Chronic liver disease liver tumor liver RESECTION REPEAT HEPATECTOMY Bridging therapy to transplantation ASCITES postoperative liver failure
下载PDF
Extracorporeal continuous portal diversion plus temporal plasmapheresis for “small-for-size” syndrome 被引量:4
5
作者 Peng Hou Chao Chen +2 位作者 Yu-Liang Tu Zi-Man Zhu Jing-Wang Tan 《World Journal of Gastroenterology》 SCIE CAS 2013年第33期5464-5472,共9页
AIM:To investigate the effect of plasmapheresis via the portal vein for"small-for-size"syndrome(SFSS)aided by extracorporeal continuous portal diversion(ECPD).METHODS:Extensive or total hepatectomy in the pi... AIM:To investigate the effect of plasmapheresis via the portal vein for"small-for-size"syndrome(SFSS)aided by extracorporeal continuous portal diversion(ECPD).METHODS:Extensive or total hepatectomy in the pig is usually adopted as a postoperative liver failure(PLF)or SFSS model.In this study,animals which underwent85%-90%hepatectomy were randomized into either the Systemic group(n=7)or the Portal group(n=7).In the Systemic group,all pigs received temporal plasmapheresis(PP)via the extracorporeal catheter circuit(systemic to systemic circulation)from 24 to 30 h posthepatectomy(PH);in the Portal group,all pigs received ECPD to divert partial portal vein flow(PVF)to the systemic circulation after hepatectomy,then converted to temporal PP from 24 to 30 h PH,and subsequently converted to ECPD again until 48 h PH.In the Portal group,the PVF was preserved at 3.0-3.3 times that of the baseline value,similar to that following 70%hepatectomy,which was regarded as the optimal PVF to the hypertrophic liver remnant.At 48 h PH,all pigs were re-opened and the portal vein pressure(PVP),PVF,and HAF(hepatic artery flow)were measured,and then diversion of the portal venous flow was terminated.After1 h the PVP,PVF,and HAF were re-measured.The portal hemodynamic changes,liver injury,liver regeneration and bacterial/lipopolysaccharide(LPS)translocation were evaluated in the two groups.RESULTS:The PVP in the Portal group was significantly lower than that in the Systemic group during the time period from 2 to 49 h PH(P<0.05).Serum alanine aminotransferase(ALT),total bilirubin(TB)and ammonia were significantly reduced in the Portal group compared with the Systemic group from 24 to 48 h PH(P<0.05).The Portal group may have attenuated sinusoidal endothelial injury and decreased the level of HA compared with the Systemic group.In the Systemic group,there was significant sinusoidal dilation,hydropic changes in hepatocytes and hemorrhage into the hepatic parenchyma,and the sinusoidal endothelial lining was partially destroyed and detached int 展开更多
关键词 Small-for-size syndrome postoperative liver failure EXTRACORPOREAL PORTAL DIVERSION PLASMAPHERESIS HEPATECTOMY
下载PDF
吲哚菁绿试验对小肝癌治疗策略选择的临床应用分析 被引量:4
6
作者 陈书德 林一鹏 +2 位作者 张文智 卢鹏 陈志晔 《肝胆胰外科杂志》 CAS 2020年第9期516-519,525,共5页
目的探讨吲哚菁绿试验在小肝癌治疗策略选择中的临床应用。方法回顾性分析2017年1月至2019年1月解放军总医院海南医院肝胆外科60例小肝癌患者的临床资料。根据治疗方式不同分为肝切除术组(36例)和射频消融术组(24例),再根据术后是否出... 目的探讨吲哚菁绿试验在小肝癌治疗策略选择中的临床应用。方法回顾性分析2017年1月至2019年1月解放军总医院海南医院肝胆外科60例小肝癌患者的临床资料。根据治疗方式不同分为肝切除术组(36例)和射频消融术组(24例),再根据术后是否出现肝衰竭分别把两组分为术后肝衰竭亚组及术后非肝衰竭亚组,比较不同组别的临床资料、吲哚菁绿15 min滞留率(ICG-R15)、Child-Pugh(CP)分值的差异。根据不同的ICG-R15,将肝切除术组及射频消融术组患者再分为ICG-R15<20%亚组、20%≤ICGR15<30%亚组和ICG-R15≥30%亚组,比较相应分组手术后肝衰竭发生率。结果肝切除术组和射频消融术组术前检查及临床资料差异均无统计学意义(P>0.05),ICG-R15、CP分值差异两组有统计学意义(P<0.05)。ICG-R15<20%亚组、20%≤ICG-R15<30%亚组和ICG-R15≥30%亚组的肝切除术患者肝衰竭率分别为6.3%、33.3%、37.5%,射频消融术组对应的肝衰竭率分别为0、12.5%、28.6%。两组的20%≤ICG-R15<30%亚组肝衰竭率具有统计学差异(P<0.05);ICG-R15<20%及ICG-R15≥30%亚组肝衰竭率无统计学差异(P>0.05)。结论ICG-R15是术前评估肝储备功能的可靠指标,对小肝癌手术方式选择具有指导意义。当ICG-R15<20%,手术切除和射频消融治疗小肝癌安全性都高;当20%≤ICG-R15<30%,射频消融术较肝切除术安全性更高;当ICG-R15≥30%,两种手术方式出现肝衰竭风险都较大,应纠正肝功能后再进一步评估手术方式。 展开更多
关键词 小肝癌 吲哚菁绿试验 肝切除术 射频消融术 术后肝衰竭
下载PDF
抗凝血酶Ⅲ在预测肝细胞癌术后肝衰竭中的应用价值 被引量:4
7
作者 王诚 陈厚斌 +3 位作者 田泽彬 郑直 黄安华 黄伟 《实用临床医药杂志》 CAS 2019年第20期66-69,共4页
目的 探讨肝细胞癌患者术前血清抗凝血酶Ⅲ(AT-Ⅲ)在预测术后发生肝功能衰竭的应用价值.方法 将本院接受肝癌手术的31例患者根据术后肝功能恢复情况分为肝衰竭组(n=7)和非衰竭组(n=24).比较2组常规肝功能指标及AT-Ⅲ活性,探讨影响肝癌... 目的 探讨肝细胞癌患者术前血清抗凝血酶Ⅲ(AT-Ⅲ)在预测术后发生肝功能衰竭的应用价值.方法 将本院接受肝癌手术的31例患者根据术后肝功能恢复情况分为肝衰竭组(n=7)和非衰竭组(n=24).比较2组常规肝功能指标及AT-Ⅲ活性,探讨影响肝癌术后肝功能衰竭的危险因素.结果 2组总胆红素、AT-Ⅲ活性、白蛋白、血小板、国际标准化比值差异有统计学意义(P<0.05).Logistic多因素分析显示,总胆红素、AT-Ⅲ是术后肝衰竭的独立危险因素(P<0.05).ROC曲线分析表明,AT-Ⅲ预测术后肝功能衰竭的最佳临界值为87.2%,其灵敏度和特异度分别为0.807和0.716,与血清总胆红素相比差异有统计学意义(P<0.05).结论 AT-Ⅲ是肝癌术后发生肝衰竭的独立危险因素,其在预测术后肝衰竭的灵敏度和特异度较血清总胆红素高. 展开更多
关键词 肝细胞癌 抗凝血酶Ⅲ 术后肝衰竭 总胆红素 危险因素
下载PDF
肝脏储备功能与肝癌术式选择 被引量:7
8
作者 孙惠川 沈英皓 李小龙 《中国实用外科杂志》 CSCD 北大核心 2018年第4期473-476,共4页
肝脏储备功能的评估始终伴随着肝脏外科的发展过程。所谓肝脏储备功能,是指在承受损伤时,肝脏继续履行或者修复后继续履行其生理功能的能力。
关键词 肝切除 术后肝功能衰竭 肝储备功能 肝脏硬度
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部